Insmed (INSM) Cash from Investing Activities (2010 - 2026)

Insmed's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at $265.5 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 230.2% year-over-year to $265.5 million; the TTM figure through Mar 2026 stood at $120.5 million (up 115.1% YoY), while the FY2025 annual figure was -$64.6 million, up 88.93% from the prior year.
• Cash from Investing Activities was $265.5 million for Q1 2026 at Insmed, down from $389.4 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $389.4 million in Q4 2025 to a low of -$1.0 billion in Q3 2024.
• Historically, Cash from Investing Activities has averaged -$37.7 million across 5 years, with a median of $20.3 million in 2022.
• Biggest YoY gain for Cash from Investing Activities was 7207.71% in 2024; the steepest drop was 14140.45% in 2024.
• A 5-year view of Cash from Investing Activities shows it stood at $20.3 million in 2022, then sank by 91.12% to $1.8 million in 2023, then jumped by 7207.71% to $131.8 million in 2024, then jumped by 195.55% to $389.4 million in 2025, then plunged by 31.81% to $265.5 million in 2026.
• The last three Cash from Investing Activities figures came in at $265.5 million (Q1 2026), $389.4 million (Q4 2025), and -$762.2 million (Q3 2025), per Business Quant data.